Covid drug Bamlanivimab administered to first patient

The coronavirus drug bamlanivimab, which helps high-risk patients to avoid developing complications, has been administered to the first patient in the Czech Republic.

The woman, who was treated in Prague’s Thomayerova hospital, was released from hospital soon after. The hospital has 500 doses of the drug at it disposal.

Prime Minister Andrej Babiš on Friday criticized the government’s expert group for being too cautious in recommending the purchase of drugs such as bamlanivimab or regeneron.

He said the Czech Republic has been offered 10,500 doses of bamlanivimab and had only acquired 2,500. It is expecting 4,000 doses of the drug regeneron in the coming days.